ECI Encision,

BOULDER, Colo., June 27 /PRNewswire-FirstCall/ -- Encision Inc. (AMEX:ECI), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced that it will begin to manufacture its own disposable scissor inserts this summer. "Sales of our disposable scissor inserts represent approximately 50% of our sales and we believe that we will be able to achieve a major cost reduction by producing our own disposable scissor inserts," said Jack Serino, President & CEO of Encision. "We also expect to provide better control over the quality and consistency of this significant product line. By owning the process and manufacturing expertise for our disposable scissor inserts, we believe that we will add intrinsic value to Encision." "Last fiscal year, to accommodate the disposable scissor insert manufacturing, we expanded our facilities by leasing an additional 9,000 square feet of space adjacent to our present facility in Boulder. In May 2007, we entered into a lease for the manufacturing equipment. The manufacturing process is highly automated and will allow for significant volume increases without the need for significant headcount increases. Field evaluations comparing our present vendor-made disposable scissor inserts to Encision-made disposable scissor inserts have been successfully completed." Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase revenues through the Company's distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. CONTACT: Marcia McHaffie, Encision Inc., 303-444-2600, DATASOURCE: Encision Inc. CONTACT: Marcia McHaffie of Encision Inc., +1-303-444-2600, Web site: http://www.encision.com/

Copyright